Full article view 2017-09-21T12:08:00+00:00
Back to News & Insights »

Innovations in Cancer Care: Capturing What Patients Value in the Calculus of Drug Costs

As healthcare spending continues to rise, payers and providers struggle to accurately measure value to patients, and with health systems all over the world shifting towards paying for value, not just volume, these efforts have never been more important. This research brief shares novel, groundbreaking studies that have helped define the value of new oncology drugs, and recommends new criteria for framing value in cancer care.

Get the brief


    Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.